Contact Us   |   Print Page   |   Sign In   |   Join
News and Press: Member Organization News

Upcoming IPO: Gemphire Therapeutics

Wednesday, July 6, 2016   (0 Comments)
Posted by: Kate Oesterle
Share |

Biopharmaceutical company Gemphire Therapeutics (NASDAQ: GEMP) is slated to price its IPO this week, according to published reports.


Northville, Michigan-based Gemphire was co-founded by former Pfizer employees Dr. Charles Bisgaier and David Lowenschuss who licensed the rights to Pfizer's gemcabene molecule in April 2011.

Subsequently, the company hired Mina Sooch as CEO, and has been progressing its lead drug candidate gemcabene through phase 1 and phase 2 clinical trials.

Read full article.

Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal